Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Relapsed Mycosis Fungoides: early-phase trial registry

1 of 1 indexed Relapsed Mycosis Fungoides trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Relapsed Mycosis Fungoides: 1 US clinical trial tracked, 1 recruiting.

Relapsed Mycosis Fungoides is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 1 of these trials.

Enrollment posture brief

Registry condition relapsed-mycosis-fungoides

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Relapsed Mycosis Fungoid (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Relapsed Mycosis Fungoides

Relapsed Mycosis Fungoides lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Relapsed Mycosis Fungoides on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Relapsed Mycosis Fungoides is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Mayo Clinic 1 trials

Named interventions

Most-linked intervention names on Relapsed Mycosis Fungoides records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Positron Emission Tomography Procedure
1 trials
Biopsy Procedure
1 trials
Computed Tomography Procedure
1 trials
Bone Marrow Biopsy Procedure
1 trials
Biospecimen Collection Procedure
1 trials

US sites by state

Facility locations filed on Relapsed Mycosis Fungoides trials. A trial with sites in several states counts in each.

Minnesota 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Relapsed Mycosis Fungoides page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Relapsed Mycosis Fungoides trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Relapsed Mycosis Fungoides trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Relapsed Mycosis Fungoides condition card totals 1 registered trials; most-linked intervention Positron Emission Tomography; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.